Evidence map›Paper›PMID 21499253›Full record

ArticleNature neuroscience2011

Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety.

Larry S Zweifel, Jonathan P Fadok, Emmanuela Argilli, Michael G Garelick, Graham L Jones, Tavis M K Dickerson, James M Allen, Sheri J Y Mizumori, Antonello Bonci, Richard D Palmiter

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 264 citations in OpenAlex.

  1. Nicotine Increases Activation to Anticipatory Valence Cues in Anterior Insula and Striatum.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Trial
  2. Trial
  3. Distinct midbrain and habenula pathways are involved in processing aversive events in humans.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Trial
  4. Article
  5. Calbindin stratifies midbrain dopaminergic neurons governing distinct aspects of locomotion.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. A neural circuit basis for reward-induced suppression of fear generalization and enhancement of fear extinction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. VTA-ACC dopaminergic circuit mediates trait anxiety-related observational learning of social avoidance in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Larry S ZweifelDepartment of Pharmacology, University of Washington, Seattle, Washington, USA. larryz@uw.edu
Jonathan P Fadok
Emmanuela Argilli
Michael G Garelick
Graham L Jones
Tavis M K Dickerson
James M Allen
Sheri J Y Mizumori
Antonello Bonci
Richard D Palmiter
University of Washington · USUniversity of California, San Francisco · USHoward Hughes Medical Institute · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
UW Initiative for Minority Student DevelopmentR25GM058501 · NIGMS · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 1999 to 2013
$5.8M
Dopamine Regulation During Context ProcessingR01MH058755 · NIMH · UNIVERSITY OF WASHINGTON · PI MIZUMORI, SHERI J. Y. · 1998 to 2012
$2.9M
Diversity Action Plan: UW GenOM ProjectR25HG007153 · NHGRI · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2020
$2.3M
Howard Hughes Medical InstituteNHGRI NIH HHS R25 HG007153NIGMS NIH HHS 2T32 GM007270NIGMS NIH HHS 4 R25 GM 058501-05NIGMS NIH HHS R25 GM058501NIGMS NIH HHS T32 GM007270NIMH NIH HHS 1 R01 MH58755NIMH NIH HHS R01 MH058755
6 · The paper itself

Abstract

Generalized anxiety is thought to result, in part, from impairments in contingency awareness during conditioning to cues that predict aversive or fearful outcomes. Dopamine neurons of the ventral midbrain exhibit heterogeneous responses to aversive stimuli that are thought to provide a critical modulatory signal to facilitate orientation to environmental changes and assignment of motivational value to unexpected events. Here we describe a mouse model in which activation of dopamine neurons in response to an aversive stimulus is attenuated by conditional genetic inactivation of functional NMDA receptors on dopamine neurons. We discovered that altering the magnitude of excitatory responses by dopamine neurons in response to an aversive stimulus was associated with impaired conditioning to a cue that predicts an aversive outcome. Impaired conditioning by these mice was associated with the development of a persistent, generalized anxiety-like phenotype. These data are consistent with a role for dopamine in facilitating contingency awareness that is critical for the prevention of generalized anxiety.

Indexed as

AnxietyAcoustic StimulationAction PotentialsAnalysis of VarianceAnimalsAvoidance LearningBehavior, AnimalBiogenic MonoaminesConditioning, PsychologicalCuesDisease Models, AnimalDopamineElectroshockExploratory BehaviorFearHydrocortisoneBiogenic MonoaminesDopamineHydrocortisoneNR1 NMDA receptorReceptors, N-Methyl-D-AspartateTyrosine 3-Monooxygenase

Identifiers

PMID21499253
PMCPMC3083461
OpenAlexW2061489284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.